Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/104547
Title: | Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? |
Author: | Bassat Orellana, Quique Menéndez, Clara |
Keywords: | Malària Administració de medicaments Malaria Administration of drugs |
Issue Date: | 16-Nov-2016 |
Publisher: | Elsevier |
Abstract: | Historically, antimalarial drugs have been used at a population level in malaria-endemic areas with the objective of decreasing the burden, impact, and transmissibility of malaria.1 Continuous chemoprophylaxis, once experimented but never seriously considered a feasible wide-scale implementable strategy, has been superseded by the concept of intermittent treatment targeting different population groups, presenting many advantages, including non-interference with the acquisition of natural immunity against malaria. |
Note: | Reproducció del document publicat a: http://dx.doi.org/10.1016/S1473-3099(16)30459-5 |
It is part of: | The Lancet. Infectious Diseases, 2016 |
URI: | http://hdl.handle.net/2445/104547 |
Related resource: | http://dx.doi.org/10.1016/S1473-3099(16)30459-5 |
ISSN: | 1473-3099 |
Appears in Collections: | Articles publicats en revistes (ISGlobal) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
bassat2016_2307.pdf | 101.43 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License